Shah Jatin

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$199,991.85
Insider Sells Quantity
6
Insider Sells Sum
$111,479.75

Insider Activity of Shah Jatin

The largest purchase of all time was on 2021-05-07 and amounted to 23250 shares of Karyopharm Therapeutics Inc. for $199,992.

The largest sale of all time was on 2021-02-11 and amounted to 1748 shares of Karyopharm Therapeutics Inc. for $27,127.

Biography of Shah Jatin

No biography is available at this moment.

2022-02-17SaleKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
1,306
0.0017%
$12.12$15,833-57.42%
2022-02-07SaleKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
1,704
0.0021%
$9.86$16,805-49.61%
2021-05-07PurchaseKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
23,250
0.0317%
$8.60$199,992-12.21%
2021-02-18SaleKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
1,186
0.0016%
$14.83$17,590-42.84%
2021-02-11SaleKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
1,748
0.0024%
$15.52$27,127-45.02%
2020-07-15SaleKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
589
0.0008%
$19.46$11,462-23.92%
2020-02-19SaleKaryopharm Therapeutics Inc.
KPTI
EVP, Chief Medical Officer
1,375
0.0021%
$16.48$22,663-0.43%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.